Atlas Trials

Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma

Clinical trial NCT06902012 · RECRUITING

Trial details

NCT number
NCT06902012
Sponsor
Zhujiang Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Start date
2027-02-01
Primary completion
2028-02-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.